...also in Adam Feuerstein's article it says "The scientific community and most of Wall Street know this and have moved on from dendritic cancer vaccines. Today's buzz is antibody-based cancer immunotherapy"... and this is exactly what ENTB is working on! ...I guess that BMSN is covering both angles through both Regen and Entest!
News 
Market Data 
Discover 
AI
